BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25590690)

  • 1. PPM1D regulates p21 expression via dephoshporylation at serine 123.
    Cao R; Zhang J; Zhang M; Chen X
    Cell Cycle; 2015; 14(4):641-7. PubMed ID: 25590690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.
    Brazina J; Svadlenka J; Macurek L; Andera L; Hodny Z; Bartek J; Hanzlikova H
    Cell Cycle; 2015; 14(3):375-87. PubMed ID: 25659035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
    Zhang M; Xu E; Zhang J; Chen X
    Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.
    Yamaguchi H; Durell SR; Chatterjee DK; Anderson CW; Appella E
    Biochemistry; 2007 Nov; 46(44):12594-603. PubMed ID: 17939684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WIP1 dephosphorylation of p27
    Choi BK; Fujiwara K; Dayaram T; Darlington Y; Dickerson J; Goodell MA; Donehower LA
    Cell Cycle; 2020 Feb; 19(4):479-491. PubMed ID: 31959038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.
    Lu X; Nannenga B; Donehower LA
    Genes Dev; 2005 May; 19(10):1162-74. PubMed ID: 15870257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
    Lu X; Nguyen TA; Donehower LA
    Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Inoue Y; Yamashita N; Kitao H; Tanaka K; Saeki H; Oki E; Oda Y; Tokunaga E; Maehara Y
    Clin Breast Cancer; 2018 Aug; 18(4):e643-e650. PubMed ID: 29275106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
    Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
    Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
    Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
    Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.
    Nannenga B; Lu X; Dumble M; Van Maanen M; Nguyen TA; Sutton R; Kumar TR; Donehower LA
    Mol Carcinog; 2006 Aug; 45(8):594-604. PubMed ID: 16652371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1).
    Kloet DE; Polderman PE; Eijkelenboom A; Smits LM; van Triest MH; van den Berg MC; Groot Koerkamp MJ; van Leenen D; Lijnzaad P; Holstege FC; Burgering BM
    Biochem J; 2015 Jul; 469(2):289-98. PubMed ID: 25990325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 2Cgamma regulates the level of p21Cip1/WAF1 by Akt signaling.
    Suh EJ; Kim YJ; Kim SH
    Biochem Biophys Res Commun; 2009 Aug; 386(3):467-70. PubMed ID: 19538940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the active site and a unique uncompetitive inhibitor of the PPM1-type protein phosphatase PPM1D.
    Chuman Y; Yagi H; Fukuda T; Nomura T; Matsukizono M; Shimohigashi Y; Sakaguchi K
    Protein Pept Lett; 2008; 15(9):938-48. PubMed ID: 18991770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type p53-induced phosphatase 1 (Wip1) forestalls cellular premature senescence at physiological oxygen levels by regulating DNA damage response signaling during DNA replication.
    Sakai H; Fujigaki H; Mazur SJ; Appella E
    Cell Cycle; 2014; 13(6):1015-29. PubMed ID: 24552809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
    Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
    Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells.
    Zhang C; Chen Y; Wang M; Chen X; Li Y; Song E; Liu X; Kim S; Peng H
    World J Surg Oncol; 2014 Aug; 12():258. PubMed ID: 25123458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PP2Cgamma-mediated S-phase accumulation induced by the proteasome-dependent degradation of p21(WAF1/CIP1).
    Suh EJ; Kim TY; Kim SH
    FEBS Lett; 2006 Nov; 580(26):6100-4. PubMed ID: 17054950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.